Seeber Andreas


list of publications

Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab

Seeber A, Braicu I, Untergasser G, Nassir M, Fong D, Botta L, Gastl G, Fiegl H, Zeimet A, Sehouli J, Spizzo G.

Oncotarget 10 Jul 2015; (). Epub ahead of print

Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro.

Seeber A, Martowicz A, Spizzo G, Buratti T, Obrist P, Fong D, Gastl G, Untergasser G.

BMC Cancer. 7 May 2015; 15(1)372.

Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.

Kocher F, Hilbe W, Seeber A, Pircher A, Schmid T, Greil R, Auberger J, Nevinny-Stickel M, Sterlacci W, Tzankov A, Jamnig H, Kohler K, Zabernigg A, Frötscher J, Oberaigner W, Fiegl M

Lung Cancer 1 Feb 2015; 87(2)193-200.

Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.

Florian K, Wolfgang H, Andreas S, Andreas P, Thomas S, Richard G, Jutta A, Meinhard NS, William S, Alexandar T, Herbert J, Karin K, August Z, Josef F, Wilhelm O, Michael F

Lung Cancer 18 Dec 2014; 87(2)193-200.

Expression of EpCAMMF and EpCAMMT variants in human carcinomas.

Fong D, Seeber A, Terracciano L, Kasal A, Mazzoleni G, Lehne F, Gastl G, Spizzo G.

J Clin Pathol. 1 May 2014; 67(5)408-14.

Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer

Fong D, Moser P, Kasal A, Seeber A, Gastl G, Martowicz A, Wurm M, Mian C, Obrist P, Mazzoleni G, Spizzo G

Histopathology 1 Oct 2013; epub().

Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.

Fong D, Spizzo G, Mitterer M, Seeber A, Steurer M, Gastl G, Brosch I, Moser P.

Ann Surg Oncol 1 Dec 2012; 19(13)4330-6.